BioLife Solutions Inc  

(Public, NASDAQ:BLFS)   Watch this stock  
Find more results for BLFS
5.92
+0.23 (4.04%)
Nov 17 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 5.70 - 6.02
52 week 1.50 - 7.53
Open 5.70
Vol / Avg. 98,589.00/212,248.00
Mkt cap 80.69M
P/E     -
Div/yield     -
EPS -0.42
Shares 13.63M
Beta 0.26
Inst. own 10%
Nov 9, 2017
Q3 2017 BioLife Solutions Inc Earnings Call
Nov 9, 2017
Q3 2017 BioLife Solutions Inc Earnings Release
Sep 11, 2017
BioLife Solutions Inc at Rodman & Renshaw Global Investment Conference
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '17) 2016
Net profit margin -10.76% -97.74%
Operating margin -1.09% -58.97%
EBITD margin - -54.50%
Return on average assets -14.73% -79.24%
Return on average equity -24.29% -117.78%
Employees 35 -
CDP Score - -

Address

3303 Monte Villa Pkwy Ste 310
BOTHELL, WA 98021-6200
United States - Map
+1-425-4011400 (Phone)
+1-425-4021433 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

BioLife Solutions, Inc. (BioLife) is engaged in the developing, manufacturing and marketing a portfolio of biopreservation tools and services for cells, tissues and organs, including clinical grade cell and tissue hypothermic storage and cryopreservation freeze media and a related cloud hosted biologistics cold chain management application for shippers. The Company's product offerings include hypothermic storage and cryopreservation freeze media products for cells, tissues, and organs; generic blood stem cell freezing and cell thawing media products; custom product formulation and custom packaging services; cold chain logistics services incorporating precision thermal packaging products and cloud-hosted Web applications, and contract aseptic manufacturing formulation, fill and finish services of liquid media products. Its products include HypoThermosol FRS, CryoStor, BloodStor, Cell Thawing Media, PrepaStor and biologistex cold-chain management service.

Officers and directors

Raymond Wayne Cohen Independent Chairman of the Board
Age: 58
Bio & Compensation  - Reuters
Michael Rice President, Chief Executive Officer, Chief Accounting Officer, Director
Age: 53
Bio & Compensation  - Reuters
Roderick de Greef Chief Financial Officer, Secretary
Age: 56
Bio & Compensation  - Reuters
Aby J. Mathew Ph.D. Senior Vice President, Chief Technology Officer
Age: 44
Bio & Compensation  - Reuters
Karen A Foster Vice President - Operations
Bio & Compensation  - Reuters
James Mathers Vice President of Sales
Bio & Compensation  - Reuters
Todd Berard Vice President - Marketing
Age: 47
Bio & Compensation  - Reuters
Thomas Girschweiler Independent Director
Age: 58
Bio & Compensation  - Reuters
Andrew G. Hinson Independent Director
Age: 53
Bio & Compensation  - Reuters
Joseph Schick Independent Director
Age: 54
Bio & Compensation  - Reuters